Tania Véliz Rodríguez
Aimmune Therapeutics (United Kingdom)(GB)
Publications by Year
Research Areas
Immune Cell Function and Interaction, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Targeting Macrophages Sensitizes Chronic Lymphocytic Leukemia to Apoptosis and Inhibits Disease Progression(2016)112 cited
- → Regulated Expansion and Survival of Chimeric Antigen Receptor-Modified T Cells Using Small Molecule-Dependent Inducible MyD88/CD40(2017)104 cited
- → The Therapeutic Potential of the Humoral Pattern Recognition Molecule PTX3 in Chronic Lung Infection Caused by Pseudomonas aeruginosa(2011)88 cited
- → TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1(2017)56 cited
- → Role of Toll Interleukin-1 Receptor (IL-1R) 8, a Negative Regulator of IL-1R/Toll-Like Receptor Signaling, in Resistance to Acute Pseudomonas aeruginosa Lung Infection(2011)52 cited
- → Lack of TIR8/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models(2011)51 cited
- → Regulatory pathways in inflammation(2007)39 cited
- → Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia(2022)23 cited
- → The inhibitory receptor toll interleukin-1R 8 (TIR8/IL-1R8/SIGIRR) is downregulated in chronic lymphocytic leukemia(2017)10 cited
- → SIGLEC-G deficiency increases susceptibility to develop B-cell lymphoproliferative disorders(2014)9 cited